Home
Middle East, North Africa    
North America
South America
Europe
Middle East / Africa
Asia / Pacific
View All Countries
×
×

Antimicrobial resistance

In an ideal world, life-threatening pathogens in your institution would be detected, identified and accurately tested for antibiotic susceptibility in order to enable the best treatment management decision.

But in the current state it is estimated that 63·5% of cases of infections with antibiotic-resistant bacteria are associated with healthcare1

Higher mortality

Resistant infections can lead to higher mortality and are often more expensive to treat than susceptible infections2

Up to 50%

of all antibiotics prescribed in European hospitals are inappropriate or unnecessary3

Excess length of stay

Resistant infections were found to increase excess length of stay (LOS) by 4.9-9.3 days4

“An accurate diagnosis is the first step to getting effective treatment. No one should suffer or die because of a lack of diagnostic services, or because the right tests were not available.”

Director General of the World Health Organization

 

Beyond the medical and economic burden on the hospital, antimicrobial resistance leads to an organisational burden in the hospital (patient isolation) and administrative burden (reporting).

The challenges lie in patient screening and the implementation of evidence-based practice interventions to enable appropriate target antibiotherapy5.

An integrated stewardship model with a holistic approach based on antimicrobial, infection prevention and diagnostic can help fight antimicrobial resistance6.

 

How BD supports you

BD supports you in implementing antimicrobial stewardship programmes overview.

Infection prevention

BD supports you in enhancing compliance to guidelines and offers you safe alternatives to help reduce SSIs, CAUTIs and CRBSIs with a portfolio of solutions which include innovative technologies and services.

Sample quality

BD supports you in improving sample quality by optimising processes and standardising practices with a portfolio of solutions which include innovative technologies and services.

Diagnostic accuracy and timeliness​

BD supports more rapid, accurate and appropriate diagnostic identification enabling effective clinical decision-making that aid in mitigating antimicrobial resistance with a portfolio of solutions which include innovative technologies and services.

Surveillance and reporting

BD supports you in enabling remote multi-site diagnostic result availability with digital infrastructure for faster decision-making with a porfolio of solutions which include innovative technologies and services.

BD supports change management and continuous quality improvement.

Learn more

Sepsis

The complete implementation of a sepsis bundle can help lower the risk of mortality associated with sepsis by 31%.

Learn more

Healthcare-associated infections

Increased compliance to guidelines and standardized practices help decrease HAIs.

Learn more

Medication errors

Standardisation processes, full traceability, automation and closed-loop mediaction management can help prevent medication errors.

Learn more

*This content is intended for healthcare professionals only.
**Not all products, services or features of products and services may be available in your local area. Please check with your local BD representative.

References
  1. Cassini A, Högberg L, Plachouras D, Quattrocchi A, Hoxha A et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. 2019;19(1):56-66
  2. Filice GA, Nyman JA, Lexau C, et al. Excess Costs and Utilization Associated with Methicillin Resistance for Patients with Staphylococcus aureus Infection. Infect Control Hosp Epidemiol. 2010;31(4):365-373.
  3. European Centre for Disease Prevention and Control. Antibiotics: handle with care! 2017. Accessed on 11 January 2019, at https://antibiotic.ecdc.europa.eu/en/infographics-about-antibiotic-stewardship-programmes.
  4. Stewardson AJ, Allignol A, Beyersmann J, et al. The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study. Euro Surveill. 2016;21(33):30319.
  5. Dyar OJ, Beović B, Pulcini C, et al. ESCMID generic competencies in antimicrobial prescribing and stewardship: towards a European consensus. Clinical Microbiology and Infection. 2019;25(1):13-19. doi:10.1016/j.cmi.2018.09.022
  6. Dik J-WH, Poelman R, Friedrich AW, et al. An integrated stewardship model: antimicrobial, infection prevention and diagnostic (AID). Future Microbiol. 2015;11(1):93-102. doi:10.2217/fmb.15.99"
Offerings
Company
Support